KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in IntangiblesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Acquisitions (2023 - 2025)

Historic Acquisitions for Astrazeneca (AZN) over the last 4 years, with Q4 2025 value amounting to -$6.0 million.

  • Astrazeneca's Acquisitions changed N/A to -$6.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.1 billion, marking a year-over-year increase of 2598.34%. This contributed to the annual value of -$66.0 million for FY2025, which is 9761.82% up from last year.
  • Per Astrazeneca's latest filing, its Acquisitions stood at -$6.0 million for Q4 2025.
  • Astrazeneca's 5-year Acquisitions high stood at -$6.0 million for Q4 2025, and its period low was -$2.0 billion during Q2 2024.
  • For the 3-year period, Astrazeneca's Acquisitions averaged around -$741.5 million, with its median value being -$457.5 million (2023).
  • Data for Astrazeneca's Acquisitions shows a peak YoY increase of 28412.7% (in 2024) and a maximum YoY decrease of 28412.7% (in 2024) over the last 5 years.
  • Over the past 3 years, Astrazeneca's Acquisitions (Quarter) stood at -$189.0 million in 2023, then tumbled by 982.01% to -$2.0 billion in 2024, then surged by 99.71% to -$6.0 million in 2025.
  • Its Acquisitions stands at -$6.0 million for Q4 2025, versus -$2.0 billion for Q2 2024 and -$726.0 million for Q1 2024.